Evidence map›Paper›PMID 42799855›Full record

ReviewJournal of community genetics2026

Considering seriousness in preconception carrier screening: a framework to support policy deliberation.

Erika Kleiderman, Anne-Marie Laberge, Lisa Dive, Vardit Ravitsky, Bartha M Knoppers, Felicity Boardman

Abstract readReview
In one paragraph

Review in Journal of community genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Erika KleidermanDepartment of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montreal, QC, Canada. erika.kleiderman.1@umontreal.ca.ORCID http://orcid.org/0000-0002-0242-2296
Anne-Marie LabergeDepartment of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montreal, QC, Canada.ORCID http://orcid.org/0000-0003-1213-8288
Lisa DiveSchool of Clinical and Health Sciences, University of Technology Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0001-6655-5138
Vardit RavitskyThe Hastings Center for Bioethics, Garrison, NY, USA.ORCID http://orcid.org/0000-0002-7080-8801
Bartha M KnoppersCentre of Genomics and Policy, Department of Human Genetics, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.ORCID http://orcid.org/0000-0001-7004-2722
Felicity BoardmanDivision of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.ORCID http://orcid.org/0000-0002-3268-6276

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe seriousness of a genetic condition has long been a central consideration in population-based screening programs. Yet, despite its widespread use in policy and practice, "serious" remains an ill-defined and multi-faceted concept. This lack of definitional clarity, complexity, and absence of guidance around how to interpret the concept has led to inconsistencies in application in policy and practice.

objectiveIn this article, we use the example of preconception carrier screening (PCS) to expand on the procedural elements of our conceptual framework for considering seriousness and lay out questions to help guide and structure deliberations about gene panel composition in the context of PCS. MAIN CONTENT: We argue that traditional attempts to operationalize seriousness, while useful, are insufficient for capturing the concept's complexity in population-based interventions. Instead, our framework - by integrating clinical, contextual, and experiential dimensions - encourages deliberation that reflects and is responsive to the diverse values and needs of communities affected by genetic conditions.

conclusionsBy fostering a balanced and context-sensitive approach, our framework offers a conceptual tool to help policymakers navigate the ethical complexities of PCS and support the development of PCS programs that are ethically defensible, socially responsible, and are aligned with the goals of community genetics.

Indexed as

Community geneticsPopulation healthPreconception carrier screeningPublic health policySerious

Identifiers

PMID42799855
PMCPMC13615949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.